[Cerebral damage due to hypoglycaemia in otherwise healthy breast-fed term infants]

S Buitendijk1, L S de Vries, F Groenendaal

  • 1VieCuri, Medisch Centrum voor Noord-Limburg, afd. Kindergeneeskunde, Venlo/Venray.

Insights

Severe hypoglycemia in breast-fed infants can cause brain damage. Early recognition of risk factors like prolonged hypothermia is crucial for prevention and prompt intervention in neonatal hypoglycemia.

Area of Science:

  • Neonatal Medicine
  • Pediatric Neurology

Background:

  • Breast-fed term infants are generally considered low-risk for metabolic disturbances.
  • Hypoglycemia can present with non-specific symptoms in neonates, leading to delayed diagnosis.

Observation:

  • Two healthy, breast-fed term infants presented with symptomatic hypoglycemia and seizures.
  • Risk factors, including hypothermia, were unrecognized until apnea or seizures occurred.
  • Both infants required antiepileptic medication for neonatal seizures.

Findings:

  • One infant experienced restricted head growth and later developed cognitive impairment and epilepsy by 11 years.
  • The second infant had normal head circumference and mild global developmental delay at 36 months.
  • Severe symptomatic hypoglycemia in this cohort led to significant neurodevelopmental deficits.

Implications:

  • Early identification of risk factors, such as hypothermia exceeding 3 hours, is critical for preventing neonatal hypoglycemia.
  • Supplemental bottle-feeding may be necessary when risk factors are present to ensure adequate intake.
  • Prompt investigation of any suspected hypoglycemia symptoms is essential to mitigate potential brain damage.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...